Bridgeway Capital Management’s Harpoon Therapeutics, Inc. Common Stock HARP Stock Holding History

Bridgeway Capital Management’s Portfolio HARP Stock Details HARP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-8,800	Closed	-$62.5K	–	1460
2023 Q2	$62.5K	Sell	8,800 -1,200	-12%	-$8.3K	﹤0.01%	1315
2023 Q1	$74.4K	Buy	10,000 +5,000	+100%	+$42K	﹤0.01%	1274
2022 Q4	$36.3K	Sell	5,000 -440	-8%	-$3.71K	﹤0.01%	1321
2022 Q3	$53K	Hold	5,440	–	–	﹤0.01%	1347
2022 Q2	$104K	Sell	5,440 -4,186	-43%	-$108K	﹤0.01%	1217
2022 Q1	$478K	Buy	+9,626	New	+$499K	0.01%	949

Other funds holding HARP

MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return

NLVP

New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return

MAM

MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return

SCM

Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

LPC

Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

Bridgeway Capital Management's HARP Position: Q3 2023 in Review

Bridgeway Capital Management sold out of Harpoon Therapeutics, Inc. Common Stock (HARP) in Q3 2023, closing a stake of 8,800 shares — an estimated $62.5K sold.

Bridgeway Capital Management first reported a position in HARP in Q1 2022 and held it in 6 quarters. The position peaked at $478K in Q1 2022. 32 funds tracked by Wall St. Rank hold HARP as of Q3 2023.

Bridgeway Capital Management reported no remaining Harpoon Therapeutics, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
Bridgeway Capital Management sold 8,800 Harpoon Therapeutics, Inc. Common Stock shares in Q3 2023, an estimated $62.5K.
Bridgeway Capital Management first reported a position in Harpoon Therapeutics, Inc. Common Stock in Q1 2022 and held it in 6 quarters.
Bridgeway Capital Management's Harpoon Therapeutics, Inc. Common Stock position peaked at $478K in Q1 2022.
32 funds tracked by Wall St. Rank held Harpoon Therapeutics, Inc. Common Stock as of Q3 2023.

Based on Bridgeway Capital Management's 13F filing for Q3 2023, filed 14 Nov 2023.